BVXV - BiondVax Pharmaceuti...

BiondVax Pharmaceuticals Ltd.

BVXV

NASDAQ

Inactive Equity

BiondVax Pharmaceuticals Ltd., a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious diseases and other illnesses in Israel. The company has licensing and collaboration agreement with Max Planck Society and University Medical Center Göttingen for the development and commercialization of COVID-19 nanosized antibody (NanoAb); and development and commercialization of NanoAbs for various other disease indications. The company was incorporated in 2003 and is headquartered in Jerusalem, Israel.

1.36 USD

0.01 (0.735%)

Overview Profile Financial Statements Financial Ratios Chart Analysis News Corporate Actions DCF

BVXV Ratings

Upgrades & Downgrades

We are unable to load this data!

Price Targets

We are unable to load the data!

FMP

Home Terms of Service Privacy Policy Blog Careers FAQs Contact Us

API

Documentation Pricing Formulas Market Indexes

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.